EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
3,607,852
Share change
-375,844
Total reported value
$44,703,000
Price per share
$12.40
Number of holders
32
Value change
-$5,870,552
Number of buys
17
Number of sells
14

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2020

As of 30 Jun 2020, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,607,852 shares. The largest 10 holders included RTW INVESTMENTS, LP, WASATCH ADVISORS INC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, VICTORY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Russell Investments Group, Ltd., and NORTHERN TRUST CORP. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.